124 related articles for article (PubMed ID: 23198758)
1. Editorial: Recombinant human bone morphogenetic protein-2.
Shaffrey CI; Smith JS
J Neurosurg Spine; 2013 Feb; 18(2):109-10; discussion 110-1. PubMed ID: 23198758
[No Abstract] [Full Text] [Related]
2. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
Burkus JK; Dryer RF; Peloza JH
J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
[TBL] [Abstract][Full Text] [Related]
3. Commentary: Retrograde ejaculation and the use of rhBMP-2 for anterior lumbar interbody fusion: what does the evidence say to surgeons and to patients?
Mroz TE; Abdullah KG; Benzel EC
Spine J; 2012 Oct; 12(10):891-3. PubMed ID: 23199820
[No Abstract] [Full Text] [Related]
4. Symptomatic heterotopic bone formation after rhBMP-2 utilization in lateral lumbar interbody fusion.
Aichmair A; Girardi FP; Hughes AP; Sama AA; Lebl DR; Cammisa FP
Spine J; 2013 Oct; 13(10):1411-2. PubMed ID: 24139750
[No Abstract] [Full Text] [Related]
5. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.
Comer GC; Smith MW; Hurwitz EL; Mitsunaga KA; Kessler R; Carragee EJ
Spine J; 2012 Oct; 12(10):881-90. PubMed ID: 23098617
[TBL] [Abstract][Full Text] [Related]
6. Editorial: No increased risk?
Hadley MN
J Neurosurg Spine; 2013 Feb; 18(2):122-4; discussion 124-5. PubMed ID: 23231360
[No Abstract] [Full Text] [Related]
7. Meta-analysis of trials of recombinant human bone morphogenetic protein-2: what should spine surgeons and their patients do with this information?
Resnick D; Bozic KJ
Ann Intern Med; 2013 Jun; 158(12):912-3. PubMed ID: 23778909
[No Abstract] [Full Text] [Related]
8. Quantitative assessment of retrograde ejaculation using semen analysis, comparison with a standardized qualitative questionnaire, and investigating the impact of rhBMP-2.
Tepper G; Rabbani R; Yousefzadeh M; Prince D
Spine (Phila Pa 1976); 2013 May; 38(10):841-5. PubMed ID: 23403551
[TBL] [Abstract][Full Text] [Related]
9. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
[TBL] [Abstract][Full Text] [Related]
10. Closing in on the truth about recombinant human bone morphogenetic protein-2: evidence synthesis, data sharing, peer review, and reproducible research.
Laine C; Guallar E; Mulrow C; Taichman DB; Cornell JE; Cotton D; Griswold ME; Localio AR; Meibohm AR; Stack CB; Williams SV; Goodman SN
Ann Intern Med; 2013 Jun; 158(12):916-8. PubMed ID: 23778911
[No Abstract] [Full Text] [Related]
11. The changing structure of industry-sponsored clinical research: pioneering data sharing and transparency.
Kuntz RE
Ann Intern Med; 2013 Jun; 158(12):914-5. PubMed ID: 23778910
[No Abstract] [Full Text] [Related]
12. Another complication associated with rhBMP-2?
Kang JD
Spine J; 2011 Jun; 11(6):517-9. PubMed ID: 21612984
[No Abstract] [Full Text] [Related]
13. An evolving perception of the risk of rhBMP-2 use for anterior spinal interbody fusions.
Smoljanovic T; Bojanic I
Spine J; 2011 Jun; 11(6):520-1. PubMed ID: 21612986
[No Abstract] [Full Text] [Related]
14. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.
Carragee EJ; Mitsunaga KA; Hurwitz EL; Scuderi GJ
Spine J; 2011 Jun; 11(6):511-6. PubMed ID: 21612985
[TBL] [Abstract][Full Text] [Related]
15. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
[TBL] [Abstract][Full Text] [Related]
16. A historic moment for open science: the Yale University Open Data Access project and medtronic.
Krumholz HM; Ross JS; Gross CP; Emanuel EJ; Hodshon B; Ritchie JD; Low JB; Lehman R
Ann Intern Med; 2013 Jun; 158(12):910-1. PubMed ID: 23778908
[No Abstract] [Full Text] [Related]
17. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.
Fu R; Selph S; McDonagh M; Peterson K; Tiwari A; Chou R; Helfand M
Ann Intern Med; 2013 Jun; 158(12):890-902. PubMed ID: 23778906
[TBL] [Abstract][Full Text] [Related]
18. Seroma observed 6 months after anterior lumbar interbody fusion that included use of recombinant bone morphogenetic protein 2.
Scheer JK; Dahdaleh NS; Smith ZA
Spine J; 2015 Oct; 15(10):e33. PubMed ID: 26022670
[No Abstract] [Full Text] [Related]
19. Symptomatic ectopic intracanal ossification after transforaminal lumbar interbody fusion with rhBMP-2.
Lehman RA; Kang DG
Spine J; 2012 Jun; 12(6):530-1. PubMed ID: 22682741
[No Abstract] [Full Text] [Related]
20. Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery.
Tannoury CA; An HS
Spine J; 2014 Mar; 14(3):552-9. PubMed ID: 24412416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]